6 Einträge gefunden

1. Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

   1. Jacobsen, Frank
   2. Taskin, Billurvan
   3. Melling, Nathaniel
   4. Sauer, Charlotte
   5. Wittmer, Corinna
   6. Hube-Magg, Claudia
   7. Kluth, Martina

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
2. p16 upregulation is linked to poor prognosis in ERG negative prostate cancer

   1. Burdelski, Christoph
   2. Dieckmann, Tatsiana
   3. Heumann, Asmus
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Beyer, Burkhard
   7. Steuber, Thomas

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
3. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
4. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
5. Marked gene transcript level alterations occur early during radical prostatectomy.

   1. Schlomm, Thorsten
   2. Näkel, Esther
   3. Lübke, Andreas
   4. Buness, Andreas
   5. Chun, Felix
   6. Steuber, Thomas
   7. Graefen, Markus

   2008 - Forschungsinformationssystem des UKE
6. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

   1. Fleischmann, Achim
   2. Schlomm, Thorsten
   3. Huland, Hartwig
   4. Köllermann, Jens
   5. Simon, Philipp
   6. Mirlacher, Martina
   7. Salomon, Georg

   2008 - Forschungsinformationssystem des UKE